Qiagen NV (QGEN)
41.86
-0.03
(-0.07%)
USD |
NYSE |
Jun 21, 16:00
41.85
-0.01
(-0.02%)
After-Hours: 20:00
Qiagen Gross Profit (Quarterly): 290.99M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 290.99M |
December 31, 2023 | 316.10M |
September 30, 2023 | 297.96M |
June 30, 2023 | 312.15M |
March 31, 2023 | 307.48M |
December 31, 2022 | 317.52M |
September 30, 2022 | 321.05M |
June 30, 2022 | 331.02M |
March 31, 2022 | 414.97M |
December 31, 2021 | 373.82M |
September 30, 2021 | 337.22M |
June 30, 2021 | 369.19M |
March 31, 2021 | 370.59M |
December 31, 2020 | 373.43M |
September 30, 2020 | 320.77M |
June 30, 2020 | 294.97M |
March 31, 2020 | 243.54M |
December 31, 2019 | 279.56M |
September 30, 2019 | 254.94M |
June 30, 2019 | 245.92M |
March 31, 2019 | 224.84M |
December 31, 2018 | 264.75M |
September 30, 2018 | 256.78M |
June 30, 2018 | 253.76M |
March 31, 2018 | 225.67M |
Date | Value |
---|---|
December 31, 2017 | 261.28M |
September 30, 2017 | 240.88M |
June 30, 2017 | 224.56M |
March 31, 2017 | 195.84M |
December 31, 2016 | 228.01M |
September 30, 2016 | 221.06M |
June 30, 2016 | 210.81M |
March 31, 2016 | 184.77M |
December 31, 2015 | 223.60M |
September 30, 2015 | 204.65M |
June 30, 2015 | 200.54M |
March 31, 2015 | 197.87M |
December 31, 2014 | 216.05M |
September 30, 2014 | 223.17M |
June 30, 2014 | 215.87M |
March 31, 2014 | 210.12M |
December 31, 2013 | 235.86M |
September 30, 2013 | 210.70M |
June 30, 2013 | 168.92M |
March 31, 2013 | 200.01M |
December 31, 2012 | 232.52M |
September 30, 2012 | 199.16M |
June 30, 2012 | 202.97M |
March 31, 2012 | 189.37M |
December 31, 2011 | 201.72M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
243.54M
Minimum
Mar 2020
414.97M
Maximum
Mar 2022
318.66M
Average
316.81M
Median
Gross Profit (Quarterly) Benchmarks
MoonLake Immunotherapeutics | -- |
LENZ Therapeutics Inc | -- |
Thermo Fisher Scientific Inc | 4.205B |
argenx SE | 357.82M |
uniQure NV | -0.741M |